CORRECTION: Arena Pharmaceuticals Awaits FDA Advisory

CORRECTION: Arena Pharmaceuticals Awaits FDA Advisory Committee
Meeting 
LOS ANGELES, CALIFORNIA -- (Marketwire) -- 05/07/12 -- Marketwire
issued a news release earlier today on behalf of Arena
Pharmaceuticals, Inc. (NASDAQ;ARNA) in error entitled, "Arena
Pharmaceuticals Awaits FDA Advisory Committee Meeting". This release
was issued without the approval of Arena Pharmaceuticals, Inc.
Editors and other readers are advised to disregard this news release. 
Marketwire regrets any inconvenience this may have caused.
Contacts:
Legitimate Market, Inc.
Market Research
250-448-1807